Amura Holdings Ltd. - Product Pipeline Review - 2014

1
Amura Holdings Ltd. - Product Pipeline Review -
2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published July 2014
• Single User PDF US 1500
• Corporate User PDF US 4500

2
Amura Holdings Ltd. - Product Pipeline Review -
2014

• Amura Holdings Ltd. - Product Pipeline Review -
  2014, provides an overview of the Amura Holdings
  Ltd.s pharmaceutical research and development
  focus.
• This report provides comprehensive information on
  the current therapeutic developmental pipeline of
  Amura Holdings Ltd.s, complete with comparative
  analysis at various stages, therapeutics
  assessment by drug target, mechanism of action
  (MoA), route of administration (RoA) and molecule
  type. It also reviews latest updates, and
  featured news and press releases, along with
  special features on late-stage and discontinued
  projects.
• Report features investigational drugs from across
  globe covering over 20 therapy areas and nearly
  3,000 indications. The report is built using data
  and information sourced from proprietary
  databases, Company/University websites, SEC
  filings, investor presentations and featured
  press releases from company/university sites and
  industry-specific third party sources. Drug
  profiles/records featured in the report undergoes
  periodic updation following a stringent set of
  processes that ensures that all the profiles are
  updated with the latest set of information.
  Additionally, processes including live news
  deals tracking, browser based alert-box and
  clinical trials registries tracking ensure that
  the most recent developments are captured on a
  real time basis.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Amura Holdings Ltd. - Product Pipeline Review -
2014

• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name291992.
• The report enhances decision making capabilities
  and help to create effective counter strategies
  to gain competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class
  products.
• Scope
• - The report provides brief overview of Amura
  Holdings Ltd. including business description, key
  information and facts, and its locations and
  subsidiaries- The report reviews current
  pipeline of Amura Holdings Ltd.s human
  therapeutic division and enlists all their major
  and minor projects- The report features product
  description and descriptive mechanism of action
  for key pipeline products along with the
  products developmental history and major
  milestones - Special feature on out-licensed and
  partnered product portfolio- The report
  summarizes all the dormant and discontinued
  pipeline projects- Latest company statement -
  Latest news and deals relating to the Amura
  Holdings Ltd.s pipeline products

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Amura Holdings Ltd. - Product Pipeline Review -
2014

• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/Discount.aspx?name291992.
• Reasons to buy
• - Evaluate Amura Holdings Ltd.s strategic
  position with total access to detailed
  information on its product pipeline- Assess the
  growth potential of Amura Holdings Ltd. in its
  therapy areas of focus- Identify new drug
  targets and therapeutic classes in the Amura
  Holdings Ltd.s RD portfolio and develop key
  strategic initiatives to reinforce pipeline in
  those areas- Exploit in-licensing opportunities
  by identifying windows of opportunity to fill
  portfolio gaps- Develop strategic initiatives by
  understanding the focus areas of Amura Holdings
  Ltd. and exploit collaboration and partnership
  opportunities- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage- Plan mergers and acquisitions
  effectively by identifying the most promising
  pipeline of Amura Holdings Ltd.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Amura Holdings Ltd. - Product Pipeline Review -
2014

• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope- Explore the
  dormant and discontinued projects of Amura
  Holdings Ltd. and identify potential
  opportunities in those areas- Avoid Intellectual
  Property Rights related issues
• Explore Report on Pharmaceuticals Market
  Therapeutic Market.
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Amura
  Holdings Ltd. - Product Pipeline Review - 2014
  report OR for any other market research and
  intelligence needs you may have for your
  business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.